KDM6A and microcephaly: Among patients with clinically diagnosed KS, 55–71% have short stature and 25–32% have microcephaly.29–31 In our cohort of patients with pathogenic KDM6A variants short stature was less frequent (48%) and microcephaly was more frequent (54%) (Supplementary Table S1).